ABOVE: Gov. Ron DeSantis. Photo via DeSantis’ Facebook.
MIAMI (AP) | LGBTQ and health groups have denounced a new rule by Florida health officials set to take effect later this month to restrict Medicaid insurance coverage for gender dysphoria treatments for transgender people.
The Florida Agency for Health Care Administration filed the new rule this month, and it is set to take effect Aug. 21, according to online records.
The state agency previously released a report stating that puberty blockers, hormones and sex reassignment surgery have not been proven safe or effective in treating gender dysphoria. Tom Wallace, the state’s deputy director of Medicaid, signed off on the report in June.
Lambda Legal, Southern Legal Counsel, Florida Health Justice Project and National Health Law Program issued a statement Aug. 11 saying the AHCA is ignoring thousands of public comments and expert testimony by finalizing a discriminatory and medically unsound rule.
“AHCA’s actions, at the behest of Governor (Ron) DeSantis and his political appointees, are morally and legally wrong, as well as medically and scientifically unsound,“ a joint statement from the groups said. “This rule represents a dangerous escalation in Governor DeSantis’s political zeal to persecute LGBTQ+ people in Florida, and particularly transgender youth.”
Transgender medical treatment for children and teens is increasingly under attack in many states where it has been labeled a form of child abuse and where Medicaid coverage is barred. Critics point to the irreversible nature of many elements of gender transition treatment.
Many doctors and mental health specialists argue that medical treatment for transgender children is safe and beneficial and can improve their well-being, although rigorous long-term research on benefits and risks is lacking. Federal guidelines say gender-affirming care is crucial to the health and well-being of transgender and nonbinary children.
Last year, the American Medical Association issued a letter urging governors to block any legislation prohibiting the treatment, calling such action “a dangerous intrusion into the practice of medicine.
